Thanks to his trusty Dexcom continuous glucose monitor (CGM), former boy band star Lance Bass is saying “bye bye bye” to ...

Experts speaking at the ADA’s Scientific Sessions supported making CGMs more accessible, but debated their usefulness for ...

Global Wearable Medical Devices Market is valued at approximately USD 59.12 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 28.6% during the forecast period ...

Lifecare said on social media that it completed a significant milestone in the development of its continuous glucose monitor ...

A research team led by Prof. Wang Long from the Ningbo Institute of Materials Technology and Engineering (NIMTE) of the ...

Continuous glucose monitoring reveals frequent dysglycaemia in very low birth weight infants nearing term age, with male sex ...

The global biosensors market is estimated to be valued at USD 31.8 billion in 2025 and is projected to reach USD 76.2 billion by 2035, registering a compound annual growth rate (CAGR) of 9.1% over the ...

The global continuous glucose monitoring device market is estimated to be valued at USD 12,690.7 million in 2025 and is projected to reach USD 54,553.1 million by 2035, registering a CAGR of 15.7% ...

DexCom, Inc. (NASDAQ:DXCM) ranks among the best fundamental stocks to buy according to hedge funds. Oppenheimer reaffirmed ...

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth ...

Neuromorphic vision sensors (NVSs) [1], which generate an event only when a pixel’s log intensity changes, feature low data redundancy and transmission latency, making them increasingly popular in ...